https://indianexpress.com/article/health-wellness/semaglutide-protect-risk-heart-attack-study-8887227/
Clinical trial showed diabetes and weight loss drug reduced major heart events by 20 per cent. This is an incremental benefit over and above controlling weight and diabetes, say experts
Create an account or login to join the discussion